4.7 Article

Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism

Journal

CANCER LETTERS
Volume 385, Issue -, Pages 12-20

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2016.10.042

Keywords

Irradiation; Caspase 3; Angiogenesis; COX-2/PGE(2); VEGF-A

Categories

Funding

  1. National Natural Science Foundation of China [81120108017, 81572951, 81172030, 81502648, 81572788]
  2. National Institutes of Health, USA [ES024015, CA155270]

Ask authors/readers for more resources

Vascular recovery or re-angiogenesis after radiotherapy plays a significant role in tumor recurrence, whereas molecular mechanisms of this process remain elusive. In this work, we found that dying glioma cells promoted post-irradiation angiogenesis through a caspase 3 dependent mechanism. Evidence in vitro and in vivo indicated that caspase 3 inhibition undermined proangiogenic effects of dying glioma cells. Proteolytic inactivation of caspase 3 in glioma cells reduced tumorigenicity. Importantly, we identified that NF-kappa B/COX-2/PGE(2) axis acted as downstream signaling of caspase 3, mediating proangiogenic response after irradiation. Additionally, VEGF-A, regulated by caspase 3 possibly through phosphorylated elF4E, was recognized as another downstream factor participating in the proangiogenic response. In conclusion, these data demonstrated that caspase 3 in dying glioma cells supported the proangiogenic response after irradiation by governing NF-kappa B/COX-2/PGE(2) axis and p-eIF4E/VEGF-A signaling. While inducing caspase 3 activation has been a generally-adopted notion in cancer therapeutics, our study counterintuitively illustrated that caspase 3 activation in dying glioma cells unfavorably supported post-irradiation angiogenesis. This double-edged role of caspase 3 suggested that taming caspase 3 from the opposite side, not always activating it, may provide novel therapeutic strategies due to restricted post-irradiation angiogenesis. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available